Multiple Myeloma Insights from Single-Cell Analysis: Clonal Evolution, the Microenvironment, Therapy Evasion, and...

Area of Science:

• Hematologic Malignancies
• Cancer Biology
• Genomics

Background:

• Multiple myeloma (MM) is a heterogeneous hematologic malignancy.
• Clonal evolution, genetic instability, and the tumor microenvironment drive MM progression and treatment resistance.
• Significant variability in patient outcomes is observed.

Purpose of the Study:

• To review mechanisms of MM progression.
• To explore the role of genetic/epigenetic changes and the bone marrow microenvironment.
• To highlight insights from single-cell technologies in understanding MM heterogeneity and drug resistance.

Main Methods:

• Review of existing literature on MM pathogenesis.
• Analysis of mechanisms including clonal evolution, genetic instability, and tumor microenvironment interactions.
• Emphasis on single-cell technologies (transcriptomics, genomics, multiomics).

Main Results:

• Single-cell technologies provide detailed understanding of MM cellular heterogeneity.
• Identification of rare cell populations and mechanisms of drug resistance is facilitated.
• Insights into the bone marrow microenvironment's role in tumor growth and immune evasion.

Conclusions:

• MM remains incurable, with ongoing challenges in applying advanced technologies (cost, data complexity, standardization).
• Continued research and collaboration are crucial for personalized treatment strategies.
• Improving patient outcomes in MM requires addressing technological and ethical considerations.